Changes in lipid metabolism in pediatric patients with severe sepsis and septic shock

Carregando...
Imagem de Miniatura
Citações na Scopus
35
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
NUTRITION, v.47, p.104-109, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: Limited knowledge exists regarding the lipid profiles of critically ill pediatric patients with systemic inflammatory response syndrome. The aim of this study was to evaluate the relationship between the intensity of the inflammatory response and changes in the lipid profiles of critically ill pediatric patients admitted to a pediatric intensive care unit (PICU) with severe sepsis/septic shock. Methods: This was a prospective and observational study at a 15-bed PICU at a public university hospital. We analyzed the lipid profiles of 40 patients with severe sepsis/septic shock admitted to the PICU on the first and seventh days of hospitalization. C-reactive protein was used as a marker for systemic inflammation. Forty-two pediatric patients seen in the emergency department and without systemic inflammatory response syndrome were used to provide control values. Results: On day 1 of admission to the PICU, the patients had significantly lower levels of total cholesterol (TC), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) as well as higher concentrations of triacylglycerols compared with the control group. There was a significant increase in the TC, HDL, LDL, and apolipoprotein levels from day 1 to day 7 of the study. Conclusions: During severe sepsis/septic shock, we found lower serum levels of lipoproteins and apolipoproteins, and these were negatively correlated with C-reactive protein. As the inflammatory response improved, the levels of TC, HDL, LDL, and apolipoproteins increased, suggesting a direct relationship between changes in the lipid profiles and inflammation.
Palavras-chave
Lipid metabolism, Intensive care units, Pediatric, Sepsis, Lipoproteins, Malnutrition
Referências
  1. Barlage S, 2001, J LIPID RES, V42, P281
  2. Barlage S, 2009, INTENS CARE MED, V35, P1877, DOI 10.1007/s00134-009-1609-y
  3. Bonville Daniel A, 2004, Surg Infect (Larchmt), V5, P39, DOI 10.1089/109629604773860291
  4. Botran M, 2011, BRIT J NUTR, V105, P731, DOI 10.1017/S0007114510004162
  5. Prieto MB, 2011, INT J ENV RES PUB HE, V8, P4353, DOI 10.3390/ijerph8114353
  6. Briassoulis G, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/354047
  7. Calder PC, 2010, INTENS CARE MED, V36, P735, DOI 10.1007/s00134-009-1744-5
  8. Cappi SB, 2012, INTENS CARE MED, V38, P634, DOI 10.1007/s00134-011-2458-z
  9. Carpentier YA, 2002, CURR OPIN CLIN NUTR, V5, P153, DOI 10.1097/00075197-200203000-00006
  10. Chammem H, 2014, J BIOMATER NANOBIOTE, V5, P153, DOI 10.4236/JBNB.2014.53018
  11. Chenaud C, 2004, CRIT CARE MED, V32, P632, DOI 10.1097/01.CCM.0000114820.47460.0A
  12. Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B
  13. de la Llera Moya Margarita, 2012, Atherosclerosis, V222, P390, DOI 10.1016/j.atherosclerosis.2012.02.032
  14. Delgado AF, 2008, CLINICS, V63, P357, DOI 10.1590/S1807-59322008000300012
  15. Fraunberger P, 1999, CLIN CHEM LAB MED, V37, P357, DOI 10.1515/CCLM.1999.059
  16. Goldstein B, 2006, PEDIATR CRIT CARE ME, V7, P200, DOI 10.1097/01.PCC.0000217470.68764.36
  17. Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011
  18. Hudgins LC, 2003, J LIPID RES, V44, P1489, DOI 10.1194/jlr.M200440-JLR200
  19. Khovidhunkit W, 2000, J INFECT DIS, V181, pS462, DOI 10.1086/315611
  20. Lekkou A, 2014, J CRIT CARE, V29, P723, DOI 10.1016/j.jcrc.2014.04.018
  21. Levels JHM, 2003, CRIT CARE MED, V31, P1647, DOI 10.1097/01.CCM.0000063260.07222.76
  22. Levels JHM, 2007, BBA-MOL CELL BIOL L, V1771, P1429, DOI 10.1016/j.bbalip.2007.10.001
  23. Luthold S, 2007, EUR J CLIN INVEST, V37, P573, DOI 10.1111/j.1365-2362.2007.01826.x
  24. Mehta NM, 2009, PEDIATR CLIN N AM, V56, P1143, DOI 10.1016/j.pcl.2009.06.007
  25. Murch O, 2007, INTENS CARE MED, V33, P13, DOI 10.1007/s00134-006-0432-y
  26. Nargis Waheeda, 2014, Int J Crit Illn Inj Sci, V4, P195, DOI 10.4103/2229-5151.141356
  27. Ngaosuwan K, 2015, J CRIT CARE, V30, P727, DOI 10.1016/j.jcrc.2015.03.026
  28. Peng YS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0832-x
  29. POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006
  30. Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2
  31. Tappenden KA, 2013, J ACAD NUTR DIET, V113, P1219, DOI 10.1016/j.jand.2013.05.015
  32. van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51
  33. Vermont CL, 2005, CRIT CARE MED, V33, P1610, DOI 10.1097/01.CCM.0000171272.50888.AD
  34. Vyroubal P, 2008, BIOMED PAP, V152, P181, DOI 10.5507/bp.2008.029
  35. Wendel M, 2007, INTENS CARE MED, V33, P25, DOI 10.1007/s00134-006-0433-x
  36. Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82
  37. Yildiz B, 2009, SCAND J INFECT DIS, V41, P263, DOI 10.1080/00365540902767056